BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29706504)

  • 1. Combined Human Genome-wide RNAi and Metabolite Analyses Identify IMPDH as a Host-Directed Target against Chlamydia Infection.
    Rother M; Gonzalez E; Teixeira da Costa AR; Wask L; Gravenstein I; Pardo M; Pietzke M; Gurumurthy RK; Angermann J; Laudeley R; Glage S; Meyer M; Chumduri C; Kempa S; Dinkel K; Unger A; Klebl B; Klos A; Meyer TF
    Cell Host Microbe; 2018 May; 23(5):661-671.e8. PubMed ID: 29706504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host and Bacterial Glycolysis during
    Ende RJ; Derré I
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32900818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphrinA2 receptor (EphA2) is an invasion and intracellular signaling receptor for Chlamydia trachomatis.
    Subbarayal P; Karunakaran K; Winkler AC; Rother M; Gonzalez E; Meyer TF; Rudel T
    PLoS Pathog; 2015 Apr; 11(4):e1004846. PubMed ID: 25906164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Host Cell Metabolism by
    Rother M; Teixeira da Costa AR; Zietlow R; Meyer TF; Rudel T
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31111817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orchestration of the mammalian host cell glucose transporter proteins-1 and 3 by Chlamydia contributes to intracellular growth and infectivity.
    Wang X; Hybiske K; Stephens RS
    Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 29040458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic adaptation of Chlamydia trachomatis to mammalian host cells.
    Mehlitz A; Eylert E; Huber C; Lindner B; Vollmuth N; Karunakaran K; Goebel W; Eisenreich W; Rudel T
    Mol Microbiol; 2017 Mar; 103(6):1004-1019. PubMed ID: 27997721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis development requires both host glycolysis and oxidative phosphorylation but has only minor effects on these pathways.
    N'Gadjaga MD; Perrinet S; Connor MG; Bertolin G; Millot GA; Subtil A
    J Biol Chem; 2022 Sep; 298(9):102338. PubMed ID: 35931114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad recruitment of mGBP family members to Chlamydia trachomatis inclusions.
    Lindenberg V; Mölleken K; Kravets E; Stallmann S; Hegemann JH; Degrandi D; Pfeffer K
    PLoS One; 2017; 12(9):e0185273. PubMed ID: 28945814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia trachomatis and its interaction with the cellular retromer.
    Banhart S; Rose L; Aeberhard L; Koch-Edelmann S; Heuer D
    Int J Med Microbiol; 2018 Jan; 308(1):197-205. PubMed ID: 29122514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming of host glutamine metabolism during Chlamydia trachomatis infection and its key role in peptidoglycan synthesis.
    Rajeeve K; Vollmuth N; Janaki-Raman S; Wulff TF; Baluapuri A; Dejure FR; Huber C; Fink J; Schmalhofer M; Schmitz W; Sivadasan R; Eilers M; Wolf E; Eisenreich W; Schulze A; Seibel J; Rudel T
    Nat Microbiol; 2020 Nov; 5(11):1390-1402. PubMed ID: 32747796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.
    Lu H; Yang X; Takeda K; Zhang D; Fan Y; Luo M; Shen C; Wang S; Akira S; Brunham RC
    Mol Med; 2000 Jul; 6(7):604-12. PubMed ID: 10997341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis remodels stable microtubules to coordinate Golgi stack recruitment to the chlamydial inclusion surface.
    Al-Zeer MA; Al-Younes HM; Kerr M; Abu-Lubad M; Gonzalez E; Brinkmann V; Meyer TF
    Mol Microbiol; 2014 Dec; 94(6):1285-97. PubMed ID: 25315131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection.
    Gurumurthy RK; Mäurer AP; Machuy N; Hess S; Pleissner KP; Schuchhardt J; Rudel T; Meyer TF
    Sci Signal; 2010 Mar; 3(113):ra21. PubMed ID: 20234004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.
    Gérard HC; Freise J; Wang Z; Roberts G; Rudy D; Krauss-Opatz B; Köhler L; Zeidler H; Schumacher HR; Whittum-Hudson JA; Hudson AP
    Microbes Infect; 2002 Jan; 4(1):13-22. PubMed ID: 11825770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia trachomatis utilizes the host cell microtubule network during early events of infection.
    Clausen JD; Christiansen G; Holst HU; Birkelund S
    Mol Microbiol; 1997 Aug; 25(3):441-9. PubMed ID: 9302007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia trachomatis targets mitochondrial dynamics to promote intracellular survival and proliferation.
    Kurihara Y; Itoh R; Shimizu A; Walenna NF; Chou B; Ishii K; Soejima T; Fujikane A; Hiromatsu K
    Cell Microbiol; 2019 Jan; 21(1):e12962. PubMed ID: 30311994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal proteomic profiling of Chlamydia trachomatis-infected HeLa-229 human cervical epithelial cells.
    Tan GM; Lim HJ; Yeow TC; Movahed E; Looi CY; Gupta R; Arulanandam BP; Abu Bakar S; Sabet NS; Chang LY; Wong WF
    Proteomics; 2016 May; 16(9):1347-60. PubMed ID: 27134121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
    Grieshaber S; Grieshaber N; Yang H; Baxter B; Hackstadt T; Omsland A
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
    Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
    Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of inosine-5'-monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease.
    Haglund S; Vikingsson S; Söderman J; Hindorf U; Grännö C; Danelius M; Coulthard S; Peterson C; Almer S
    Ther Drug Monit; 2011 Apr; 33(2):200-8. PubMed ID: 21311411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.